984 related articles for article (PubMed ID: 27272384)
1. Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells.
Kim D; Kim J; Hur JK; Been KW; Yoon SH; Kim JS
Nat Biotechnol; 2016 Aug; 34(8):863-8. PubMed ID: 27272384
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
Kleinstiver BP; Tsai SQ; Prew MS; Nguyen NT; Welch MM; Lopez JM; McCaw ZR; Aryee MJ; Joung JK
Nat Biotechnol; 2016 Aug; 34(8):869-74. PubMed ID: 27347757
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
[TBL] [Abstract][Full Text] [Related]
4. A 'new lease of life': FnCpf1 possesses DNA cleavage activity for genome editing in human cells.
Tu M; Lin L; Cheng Y; He X; Sun H; Xie H; Fu J; Liu C; Li J; Chen D; Xi H; Xue D; Liu Q; Zhao J; Gao C; Song Z; Qu J; Gu F
Nucleic Acids Res; 2017 Nov; 45(19):11295-11304. PubMed ID: 28977650
[TBL] [Abstract][Full Text] [Related]
5. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
[TBL] [Abstract][Full Text] [Related]
6. Mb- and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants.
Tóth E; Czene BC; Kulcsár PI; Krausz SL; Tálas A; Nyeste A; Varga É; Huszár K; Weinhardt N; Ligeti Z; Borsy AÉ; Fodor E; Welker E
Nucleic Acids Res; 2018 Nov; 46(19):10272-10285. PubMed ID: 30239882
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cpf1-mediated DNA-free plant genome editing.
Kim H; Kim ST; Ryu J; Kang BC; Kim JS; Kim SG
Nat Commun; 2017 Feb; 8():14406. PubMed ID: 28205546
[TBL] [Abstract][Full Text] [Related]
8. The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing.
Bayat H; Modarressi MH; Rahimpour A
Curr Microbiol; 2018 Jan; 75(1):107-115. PubMed ID: 29189942
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide specificity of dCpf1 cytidine base editors.
Kim D; Lim K; Kim DE; Kim JS
Nat Commun; 2020 Aug; 11(1):4072. PubMed ID: 32792663
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into the apo-structure of Cpf1 protein from Francisella novicida.
Min K; Yoon H; Jo I; Ha NC; Jin KS; Kim JS; Lee HH
Biochem Biophys Res Commun; 2018 Apr; 498(4):775-781. PubMed ID: 29526756
[TBL] [Abstract][Full Text] [Related]
11. Efficient genome editing in wheat using Cas9 and Cpf1 (AsCpf1 and LbCpf1) nucleases.
Kim D; Hager M; Brant E; Budak H
Funct Integr Genomics; 2021 Jul; 21(3-4):355-366. PubMed ID: 33710467
[TBL] [Abstract][Full Text] [Related]
12. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cpf1-mediated genome editing and gene regulation in human cells.
Li T; Zhu L; Xiao B; Gong Z; Liao Q; Guo J
Biotechnol Adv; 2019; 37(1):21-27. PubMed ID: 30399413
[TBL] [Abstract][Full Text] [Related]
14. Optimizing a CRISPR-Cpf1-based genome engineering system for Corynebacterium glutamicum.
Zhang J; Yang F; Yang Y; Jiang Y; Huo YX
Microb Cell Fact; 2019 Mar; 18(1):60. PubMed ID: 30909908
[TBL] [Abstract][Full Text] [Related]
15. Engineered Cpf1 variants with altered PAM specificities.
Gao L; Cox DBT; Yan WX; Manteiga JC; Schneider MW; Yamano T; Nishimasu H; Nureki O; Crosetto N; Zhang F
Nat Biotechnol; 2017 Aug; 35(8):789-792. PubMed ID: 28581492
[TBL] [Abstract][Full Text] [Related]
16. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
[TBL] [Abstract][Full Text] [Related]
17. Design and assessment of engineered CRISPR-Cpf1 and its use for genome editing.
Li B; Zeng C; Dong Y
Nat Protoc; 2018 May; 13(5):899-914. PubMed ID: 29622802
[TBL] [Abstract][Full Text] [Related]
18. In vivo high-throughput profiling of CRISPR-Cpf1 activity.
Kim HK; Song M; Lee J; Menon AV; Jung S; Kang YM; Choi JW; Woo E; Koh HC; Nam JW; Kim H
Nat Methods; 2017 Feb; 14(2):153-159. PubMed ID: 27992409
[TBL] [Abstract][Full Text] [Related]
19. Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9.
Fu BXH; Smith JD; Fuchs RT; Mabuchi M; Curcuru J; Robb GB; Fire AZ
Nat Microbiol; 2019 May; 4(5):888-897. PubMed ID: 30833733
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.
Anderson EM; Haupt A; Schiel JA; Chou E; Machado HB; Strezoska Ž; Lenger S; McClelland S; Birmingham A; Vermeulen A; Smith Av
J Biotechnol; 2015 Oct; 211():56-65. PubMed ID: 26189696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
